infertility. Female infertility, unspecified
Conditions
Interventions
Intervention 1: Intervention group: the group will be administered hMG (150–225 IU) and MPA (10 mg/d) from MC3 onward. Intervention 2: Control group: the group will be administered hMG (150–225 IU) an
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
No minimum to 42 Years
Inclusion criteria
Inclusion criteria: age under 42 years regular menstrual cycles over the previous 3-month period antral follicle count (AFC) of 7-24 on menstrual cycle day 2–3 Normal TSH and Prolactin levels
Exclusion criteria
Exclusion criteria: endometriosis grade 3 or higher diagnosis of polycystic ovarian syndrome presence of ovarian cyst hormone treatment receipt within the previous 3-month period low ovarian reserve (AMH<1.1 or AFC<7) any contraindication to ovarian stimulation treatment basal serum FSH concentration of more than 10 IU/L
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of oocytes retrieved. Timepoint: on day of oocyte retrieval. Method of measurement: count. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of mature oocytes. Timepoint: on day of oocyte retrieval. Method of measurement: count.;Clinical pregnancy. Timepoint: 3 weeks after IVF. Method of measurement: Measurement of beta-hCG.;Embryos number. Timepoint: after 24 hours and day 5. Method of measurement: microscopic evaluation.;Fertilization rate. Timepoint: 24 hours after intra-cytoplasmic sperm injection. Method of measurement: microscope.;Implantation rate. Timepoint: 2 weeks after embryo transfer. Method of measurement: Measurement of beta-hCG. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMina Moosaie
Shiraz University of Medical Sciences
Outcome results
None listed